The common form for federal-wide use for current and pending (other) support disclosure, created as directed by NSPM-33 with NSF serving as steward. The form includes certification by each senior/key person at the time of submission that they are not a party to a malign foreign talent recruitment program as defined in the CHIPS and Science Act of 2022. As of November 2025, the form has been implemented by NSF and the National Aeronautics and Space Administration (NASA).
The common form for federal-wide biographical sketch disclosure, created as directed by NSPM-33 with NSF serving as steward. Includes certification by each senior/key person at the time of submission that they are not a party to a malign foreign talent recruitment program as defined in the CHIPS and Science Act of 2022. As of November 2025, the form has been implemented by NSF and NASA.
A matrix developed to assist in determining if specific activities are required to be disclosed and what form is appropriate for reporting. Last updated May 2024.
Issued by the White House OSTP in February 2024, this policy requires federal agencies to use the Common Forms for current and pending support and biosketches, noting that NSF will serve as steward. Deviation from the common disclosure forms will require Office of Management and Budget (OMB)/Office of Information and Regulatory Affairs (OIRA) review and clearance under the Paperwork Reduction Act (PRA).
The NASA Proposer's Guide (February 2023) includes similar language to the Wolf Amendment in a footnote of section 2.16, Current and Pending Support. Per the footnote, 'China or Chinese-owned Company' means the People's Republic of China (PRC), any company owned by the PRC, or any company incorporated under the laws of the PRC. Chinese universities and other similar institutions are considered to be incorporated under the laws of the PRC and, therefore, the funding restrictions apply to grants and cooperative agreements that include bilateral participation, collaboration, or coordination with Chinese universities.
Issued on August 8, 2024. Effective May 1, 2025, applicants are required to have a Digital Persistent Identifier or Persistent Identifier (PID) if: 1. Individuals are listed within financial assistance applications that will fund R&D activities, or technical assistance to support R&D activities; and 2. Individuals are required to submit Biographical Sketch and/or Current and Pending (Other) Support disclosure. A PID is defined as globally unique, persistent, machine resolvable and processable, and has an associated metadata schema (example: ORCID iD). PIDs must be provided in the Biographical Sketch and/or Current and Pending (Other) Support disclosures as part of the application. This requirement is optional until May 1, 2025, and mandatory thereafter.
For applicants, recipients, and subrecipients that are required to submit transparency of foreign connections disclosures, DOE provides this format for the convenience of the entity providing the disclosure and certification; however, the entity is not required to use this specific format. If another format is used, the signatory must include the same substantive information, a signature, date, and the certification statement provided in Section 3 of the document.
Financial Assistance Letter FAL 2026-02, issued by the U.S. Department of Energy on December 3, 2025, mandating that any DOE notices of funding opportunities (NOFOs), including those from the National Nuclear Security Administration, issued on or after December 3, 2025, require use of the Common Forms via the SciENcv system for Biographical Sketches and Current and Pending (Other) Support (CPS). DOE's adoption of the Biosketch Common Form replaces its prior use of the Resume form, with program offices retaining latitude to specify certain data requirements (such as digital persistent identifier requirements or additional CPS disclosures) within a given NOFO.
On September 4, 2025, NIH issued notice NOT-OD-25-152, regarding the agency's plans to release preview versions of NIH's Common Forms for Biographical Sketches (Biosketches) and Current and Pending (Other) Support in the Science Experts Network Curriculum Vitae (SciENcv) system. Access to the preview versions is purely for informational purposes and applicants/recipients may not submit documents to NIH that were created using the preview functionality. Applicants/recipients must continue to use the current NIH Biosketch and Other Support forms until NIH officially implements its Common Forms, which the agency anticipates will occur in November 2025. The fall 2025 government shutdown may impact this timeline.
An NIH form used by recipients with active SBIR and STTR awards to disclose all funded and unfunded relationships with foreign countries. Per NOT-OD-25-102, recipients whose awards did not undergo foreign risk assessment at the time of their original application may be required to use this form, and NIH may terminate awards where a reported covered foreign relationship meets risk criteria prohibiting funding.
Issued December 2, 2025, NOT-OD-26-018 announces NIH's adoption of the Common Forms for Biographical Sketches and Current and Pending (Other) Support. Use of the Common Forms and the NIH Biosketch Supplement is required for applications with due dates on or after January 25, 2026, and for RPPRs and Just-In-Time responses submitted on or after that date, all completed via SciENcv. By February 6, 2026, failure to use the Common Forms generates a submission-blocking error, and the transition incorporates malign foreign talent recruitment program (MFTRP) certifications from institutions and senior/key personnel.
An NIH Guide Notice issued February 4, 2026 confirming that NIH will not withdraw initial applications, JITs, RPPRs, or Prior Approvals submitted on or after January 25 that fail to use the Common Forms via SciENcv for Biographical Sketches, Current and Pending (Other) Support, and NIH Biographical Sketch Supplements. Instead, NIH will provide a warning message when the Common Forms are not used, while still encouraging applicants and recipients to begin using the Common Forms as soon as possible.
